Daily Health Headlines

Top Zika Vaccine Candidate Moves Closer to Field Testing

👤by Dennis Thompson 0 comments 🕔Tuesday, October 4th, 2016

MONDAY, Oct. 3, 2016 (HealthDay News) -- The leading Zika vaccine candidate should be ready for field testing should new outbreaks occur next year, U.S. health officials announced Monday.

Over the weekend, researchers finished recruitment of the 80 volunteers needed for phase 1 trials of a DNA vaccine to protect against Zika, said Dr. Anthony Fauci, director of the U.S. National Institute for Allergy and Infectious Diseases (NIAID). In a Phase 1 trial, a drug or vaccine is tested in a small group, largely for safety.

"This trial is right on target -- in fact, a bit ahead of time," Fauci said. "It is projected we will have enough information to determine safety and whether it induces the kind of response we predict would be protective."

The DNA vaccine is on track for phase 2 field testing by January, if it proves safe and Zika outbreaks begin with the start of summer in South America, Fauci said. Phase 2 trials test the effectiveness of a drug or vaccine in larger numbers of people.

Researchers hope to include between 2,400 and 5,000 people in the phase 2 trials. The trials will be conducted in at least 15 locations where active Zika transmission is occurring. That could include the United States if an outbreak of Zika occurs next summer, Fauci said.

The DNA vaccine is the furthest along of nine candidate Zika vaccines, the health officials said Monday.

Developed by NIAID's Vaccine Research Center, the DNA vaccine contains a fragment of Zika's genetic makeup that has been recreated synthetically in the laboratory. The vaccine is intended to produce small virus-like particles similar enough to Zika to prompt an immune response that would shield the body against future infection from the virus.

Last month, researchers reported in the journal Science that a two-dose regimen of the DNA vaccine successfully protected 17 of 18 monkeys from Zika infection.

Zika is the first mosquito-borne virus known to cause terrible birth defects, most of them brain-related.

The most common defect is microcephaly, in which a child is born with an abnormally small brain and skull. Thousands of babies have been born with Zika-linked microcephaly, most of them in Brazil, since an outbreak began in South America in April 2015.

However, researchers have detailed so many different brain defects linked to Zika that they have now proposed using the term "congenital Zika syndrome" when reporting on future cases.

Zika infections have been occurring in south Florida since summer, with 124 cases reported as of Sept. 30, according to the U.S. Centers for Disease Control and Prevention. While 97 of those cases involved pregnant women, there have been no reports of microcephaly in the state.

Congress last week authorized $1.1 billion to fight Zika, and Fauci said the money will allow his researchers to "proceed in a smooth fashion" with the phase 2 DNA vaccine trial. For example, they will be able to produce enough doses in advance of the next Zika outbreak, he said.

Officials said the new funding also will be used to pay for:

Better research coordination between universities and public health departments, Emergency teams to react to Zika outbreaks, Expanded mosquito-control efforts, Research into long-term effects of Zika infection, particularly in children with no obvious birth defects, Preparations for major vaccine manufacturing, once a vaccine has been approved.

Article Credits / Source

Dennis Thompson / HealthDay

Dennis Thompson wrote this story for HealthDay. HealthDay provides up to the minute breaking health news. Click here to view this full article from HealthDay.

SOURCE: Oct. 3, 2016, media briefing with: Anthony Fauci, M.D., director, U.S. National Institute for Allergy and Infectious Diseases

View More Articles From Dennis Thompson 🌎View Article Website

Sponsored Product

Lunar Sleep for $1.95

Lunar Sleep for $1.95

People who have trouble sleeping typically have low levels of melatonin, so melatonin supplements seem like a logical fix for insomnia. There is a high demand for sleep aids, especially in the U.S. The National Health Interview Survey done in 2002, and again in 2007, found 1.6 million US adults were using complementary and alternative sleep aids for insomnia. Lunar Sleep was a top choice. Use Promo Code: Sleep2014 and only pay $1.95 S&H.

Get Lunar Sleep for $1.95

More Infectious Disease Articles

FDA Scientists Develop Mouse Model for Zika Research

FDA Scientists Develop Mouse Model for Zika Research0

FRIDAY, Nov. 18, 2016 (HealthDay News) -- A mouse strain developed by U.S. government scientists could help speed up research into vaccines and treatments for the Zika virus, researchers report. Newborn mice of the new strain created by U.S. ...

'Superbug' Common Among N.C. Hog Workers, Study Says

'Superbug' Common Among N.C. Hog Workers, Study Says0

FRIDAY, Nov. 18, 2016 (HealthDay News) -- Some workers at hog production facilities in the United States have skin infections from drug-resistant "superbugs," researchers report. Hogs are given antibiotics to speed their growth. But, overuse of ...

Bagged Salads May Be Fertile Ground for Bacteria

Bagged Salads May Be Fertile Ground for Bacteria0

FRIDAY, Nov. 18, 2016 (HealthDay News) -- Prepackaged salads may promote the growth of salmonella bacteria, researchers report. They found that even slight damage to leaves in salad bags released juices that encouraged the spread of ...

Zika No Longer 'Global Health Emergency,' WHO Says

Zika No Longer 'Global Health Emergency,' WHO Says0

FRIDAY, Nov. 18, 2016 (HealthDay News) -- Zika, the mosquito-borne virus that can cause severe birth defects in the infants of infected mothers, is no longer a "global health emergency," the United Nation's World Health Organization (WHO) declared ...

U.S. Hospitals Halve Catheter Infection Rates: Review

U.S. Hospitals Halve Catheter Infection Rates: Review0

MONDAY, Nov. 21, 2016 (HealthDay News) -- U.S. hospitals have cut in half the number of potentially deadly bloodstream infections linked to so-called central-line catheters since 2008. But, too many critically ill patients are still exposed to ...

View More Infectious Disease Articles


Write a Comment

Your email address will not be published. Required fields are marked *

Our Mailing List

Subscribe to our mailing list to get the latest health news as it breaks!

Your information will not be shared with anyone!